PR.24 Team Odette Cancer Centre at Sunnybrook Health Sciences Centre Wednesday, May 07, 2025 Congratulations to the PR.24 trial team from Odette Cancer Centre who were presented the Phase III Program Team Award at the 2025 Spring Meeting for their work and dedication to this CCTG led prostate cancer trial. This recognition is awarded to a non-MD team of clinical research associates, nurses, pharmacists and others who participated in this phase III clinical trial to acknowledge their efforts and dedication to the success of clinical trials."Thank you so much for this incredible honor. We at Sunnybrook GU Radiation Oncology Clinical Studies (GUROCS) Group are pleased and thrilled to receive this award. This recognition means a great deal not only to us but to our patients as well as it reflects our motivation and hard work in providing the best of care and contributing to the advancement of our prostate radiation treatments. Thank you again for this meaningful recognition. We’ll keep on GUROCkin’," acknowledged the Odette Cancer Centre team.The PR.24 team from Odette Cancer Centre at Sunnybrook Health Sciences Centre includes, Zeeba Sadiq, Vivette Escueta, Marie Alera, Mona Beera, Andrea DeAbreu, Alexandre Mamedov, Mark Bisci, Murtuza Saifuddin. The CCTG PR.24 study is a androgen suppression combined with elective nodal irradiation and dose escalated prostate treatment: a non-inferiority, phase III randomized controlled trial of stereotactic body radiation therapy versus brachytherapy boost in patients with unfavourable risk localized prostate cancer (ASCENDE-SBRT).
